JENA, Germany, March 18, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced an oral ...

InflaRx was founded in 2007 and maintains offices in Jena and Munich, Germany, and Ann Arbor, Michigan. In other recent news, InflaRx N.V. has disclosed post-hoc analyses indicating potential efficacy ...

Dr. Clarissa Souza, a board-certified veterinary dermatologist and head of the dermatology and otology service at the University of Illinois Veterinary Teaching Hospital in Urbana. Dr. Clarissa Souza, ...

India’s Supreme Court has allowed the parents of a 31-year-old man to withdraw life-sustaining treatment after more than a decade in a vegetative state, a ruling experts say could shape how the ...

The Supreme Court has permitted passive euthanasia for Harish Rana, a 31-year-old man in a permanent vegetative state since 2013 NEW DELHI: The Supreme Court has permitted the withdrawal of ...

A “No-Veg” method flips plants straight to 12/12, trading smaller individual yields for higher annual output and a dramatic jump in top-shelf buds. I have spent the better part of forty years walking ...

Add Yahoo as a preferred source to see more of our stories on Google. Aneisha DeFreitas and daughter Taneiysha "Tay" Rodriguez, 20, at their residence in Windsor, Conn., Tuesday, January 6, 2026. Tay ...

EAST WINDSOR, Conn. (WFSB) - A 21 year old man faces 22 years in prison, after being accused of causing a car accident that put his friend into a vegetative state. The I-Team first told you about ...

Exclusive: Before Randall Gamboa Esquivel died, his health had deteriorated badly while he was in ICE custody Costa Rican family demands answers after ICE deportation and death: ‘Have you ever smelled ...

A man who left Costa Rica for the United States was deported ten months later, unable to speak, move, or respond. Randall Gamboa Esquivel departed his hometown of Pérez Zeledón in December 2024 and ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...